Cargando…

Expression and prognostic value of transcription-associated cyclin-dependent kinases in human breast cancer

The expression and prognostic significance of transcription-associated cyclin-dependent kinases (TA-CDKs) in breast cancer have not been systematically investigated. Using Oncomine, GEPIA2, the Human Protein Atlas, the Kaplan-Meier Plotter, cBioPortal, Metascape, and DAVID 6.8, we profiled the expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ning, Zheng, Shaoquan, Xue, Zhicheng, Xiong, Zhenchong, Zou, Yutian, Tang, Yuhui, Wei, Wei-Dong, Yang, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034920/ https://www.ncbi.nlm.nih.gov/pubmed/33686962 http://dx.doi.org/10.18632/aging.202595

Ejemplares similares

The prognostic value of Cyclin-Dependent Kinase 5 and Protein Phosphatase 2A in Gastric Cancer
por: Lin, Jian-Xian, et al.
Publicado: (2018)

Therapeutic targeting of transcriptional cyclin-dependent kinases
por: Galbraith, Matthew D., et al.
Publicado: (2018)

Identification of a 4‐mRNA metastasis‐related prognostic signature for patients with breast cancer
por: Xie, Xinhua, et al.
Publicado: (2018)

Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients
por: van Nes, J G H, et al.
Publicado: (2009)

Expression patterns and prognostic values of the cyclin-dependent kinase 1 and cyclin A2 gene cluster in pancreatic adenocarcinoma
por: Jiang, Peng, et al.
Publicado: (2020)

The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer
por: Chiarle, Roberto, et al.
Publicado: (2001)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Requirement for A-type cyclin-dependent kinase and cyclins for the terminal division in the stomatal lineage of Arabidopsis
por: Yang, Kezhen, et al.
Publicado: (2014)

Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer
por: Constantin, Theodora A., et al.
Publicado: (2022)

Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2021)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

The Prognostic Value and Overexpression of Cyclin A Is Correlated with Gene Amplification of both Cyclin A and Cyclin E in Breast Cancer Patient
por: Husdal, A., et al.
Publicado: (2006)

Analysis of Cyclin-Dependent Kinase 1 as an Independent Prognostic Factor for Gastric Cancer Based on Statistical Methods
por: Zhang, Xu, et al.
Publicado: (2020)

Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2− Advanced Breast Cancer
por: Xie, Ning, et al.
Publicado: (2020)

Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma
por: Mo, Chaohua, et al.
Publicado: (2022)

Diagnostic and prognostic value of circular RNA CDR1as/ciRS‐7 for solid tumours: A systematic review and meta‐analysis
por: Zou, Yutian, et al.
Publicado: (2020)

Latest Overview of the Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: The Past, the Present and the Future
por: Chen, Xiu, et al.
Publicado: (2019)

Plant casein kinases phosphorylate and destabilize a cyclin-dependent kinase inhibitor to promote cell division
por: Qu, Li, et al.
Publicado: (2021)

Cyclin-dependent kinases in C. elegans
por: Boxem, Mike
Publicado: (2006)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers
por: Hur, Saem, et al.
Publicado: (2020)

The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
por: Ding, Lei, et al.
Publicado: (2020)

Cell Cycle-Dependent Transcription: The Cyclin Dependent Kinase Cdk1 Is a Direct Regulator of Basal Transcription Machineries
por: Enserink, Jorrit M., et al.
Publicado: (2022)

Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study
por: Yushan, Ruan, et al.
Publicado: (2015)

Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2020)

Correction to: Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2020)

Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis
por: Zou, Yutian, et al.
Publicado: (2020)

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer
por: Tian, Wenwen, et al.
Publicado: (2023)

The biogenesis, function and clinical significance of circular RNAs in breast cancer
por: Zeng, Yan, et al.
Publicado: (2022)

Prediction of Cyclin-Dependent Kinase Phosphorylation Substrates
por: Chang, Emmanuel J., et al.
Publicado: (2007)

Cyclin-dependent kinase control of motile ciliogenesis
por: Vladar, Eszter K, et al.
Publicado: (2018)

Cyclin-dependent kinases and rare developmental disorders
por: Colas, Pierre
Publicado: (2020)

Cyclin-dependent kinase inhibitors in malignant hematopoiesis
por: Schirripa, Alessia, et al.
Publicado: (2022)

Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration
por: Tian, Wenwen, et al.
Publicado: (2023)

Concomitant Presence of p16/Cyclin‐dependent Kinase 4 and Cyclin D/Cyclin‐dependent Kinase 4 omplexes in LNCaP Prostatic Cancer Cell Line
por: Itoh, Noriyuki, et al.
Publicado: (1997)

Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2022)

Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors
por: Rottier, Pauline, et al.
Publicado: (2023)

Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study
por: Xiao, Weikai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_atnl5m6pdhbnlq3f3hn8c9rmrl